Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Actin-Like 7b (Actl7b) Peptid

Actl7b Reaktivität: Säugetier Wirt: Synthetic BP, WB, IHC
Produktnummer ABIN939897

Kurzübersicht für Actin-Like 7b (Actl7b) Peptid (ABIN939897)

Target

Actl7b (Actin-Like 7b (Actl7b))

Spezies

Säugetier

Quelle

  • 5
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Protein-Typ

    Synthetic

    Sequenz

    KLITIGQERF RCSEMLFQPS LAGSTQPGLP ELTAACLGRC QDTGFKEEMA

    Produktmerkmale

    A synthetic peptide for use as a blocking control in assays to test for specificity of ACTL7 B antibody,
    Alternative Names: ACTL7B control peptide, ACTL7B antibody Blocking Peptide, Anti-ACTL7B Blocking Peptide, Actin-Like 7B Blocking Peptide
  • Applikationshinweise

    Optimal conditions should be determined by the investigator

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.

    Buffer

    PBS

    Handhabung

    Avoid repeated freeze/thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store at -20 °C long term.
  • Target

    Actl7b (Actin-Like 7b (Actl7b))

    Hintergrund

    ACTL7B is a member of a family of actin-related proteins (ARPs) which share significant amino acid sequence identity to conventional actins. Both actins and ARPs have an actin fold, which is an ATP-binding cleft, as a common feature. The ARPs are involved in diverse cellular processes, including vesicular transport, spindle orientation, nuclear migration and chromatin remodeling. Based on mutational analysis of the ACTL7B gene in patients with this disorder, it was concluded that it is unlikely to be involved in the pathogenesis of dysautonomia. Unlike ACTL7A, the ACTL7B gene is expressed predominantly in the testis, however, its exact function is not known.

    Molekulargewicht

    46 kDa
Sie sind hier:
Chat with us!